← Back to Search

Virtual Reality Training for Airway Injury Management Education (AW&VR Trial)

N/A
Recruiting
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥18 at time of consent
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours before and up to 24 hours after practice sessions
Awards & highlights

AW&VR Trial Summary

This trial is testing whether Virtual Reality can be used to educate medical students on airway injury management, and if it is more effective or efficient than training with a mannequin.

Who is the study for?
This trial is for University of Toronto medical students in their 1st, 2nd, or 3rd year who are at least 18 years old and can attend two sessions one week apart. It's not suitable for those without consent capacity, with visual/hearing impairments that limit VR/video use, or a history of significant motion sickness.Check my eligibility
What is being tested?
The study tests if VR-based simulation training is as effective as traditional mannequin-based simulation in teaching airway trauma management to medical students. Participants will be randomly assigned to either the VR group or the mannequin group and assessed on their skills after one week.See study design
What are the potential side effects?
Participants may experience side effects from using VR such as motion sickness (cybersickness), which includes symptoms like nausea, dizziness, or headaches.

AW&VR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

AW&VR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 hours before and up to 24 hours after practice sessions
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 hours before and up to 24 hours after practice sessions for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Application of Traumatic Airway Injury Management Knowledge
Change in Traumatic Airway Injury Management Knowledge
Secondary outcome measures
Number of Required Practice Sessions

AW&VR Trial Design

2Treatment groups
Experimental Treatment
Group I: VR-based Simulation (Intervention)Experimental Treatment1 Intervention
Students will receive training on traumatic airway management using VR-based simulation.
Group II: Mannequin-based Simulation (Control)Experimental Treatment1 Intervention
Students will receive training on traumatic airway management using mannequin-based simulation.

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,268 Total Patients Enrolled

Media Library

Mannequin-based simulation Clinical Trial Eligibility Overview. Trial Name: NCT04451590 — N/A
Airway Management Research Study Groups: VR-based Simulation (Intervention), Mannequin-based Simulation (Control)
Airway Management Clinical Trial 2023: Mannequin-based simulation Highlights & Side Effects. Trial Name: NCT04451590 — N/A
Mannequin-based simulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04451590 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being recruited for this research program?

"Affirmative. According to data posted on clinicaltrials.gov, this research is still actively recruiting participants since it was first published on August 1st 2021 and most recently updated September 12th 2022. A total of 40 patients are needed at a single medical centre for the trial's completion."

Answered by AI

What is the maximum capacity of participants being accepted into this clinical trial?

"Affirmative. Clinicaltrials.gov hosts information which points to the ongoing recruitment of participants for this medical trial, first posted on August 1st 2021 and amended most recently on September 12th 2022. The study requires 40 patients from a singular location."

Answered by AI
~7 spots leftby Dec 2024